Finance Watch: Signs Of Life? A Small Offering, Three New Filings And Galderma Hints At An IPO
Azitra Raised $7.5m In First US IPO Since Acelyrin In May
Public Company Edition: Private Galderma raised $1bn but said its next likely financing will be an IPO. Also, Azitra went public while Turnstone, Apogee and Sagimet initiated the process; Sutro signed a royalty deal for up to $390m; and despite a follow-on offering mini-surge, cost cuts continue.
